PROTXX, Inc.
PROTXX innovations in wearable sensors and machine learning transform the lives of tens of millions of people with complex neurophysiological medical conditions such as concussions, stroke, multiple sclerosis, and Parkinson’s disease. These conditions can result from injuries, disease, aging, or genetic disorders, and can lead to impairments to multiple physiological systems. Current solutions for diagnosing these multiple impairments and monitoring the effectiveness of treatments and rehabilitation require multiple time-consuming tests carried out by multiple clinical specialists using expensive lab equipment. The PROTXX PHYsiological viBRATion Acceleration (PHYBRATA) sensor delivers an innovative solution to this problem by enabling much easier to use, lower cost, in-clinic-and remote assessments and management of these multiple impairments. The PHYBRATA sensor attaches behind the ear using a small disposable adhesive and detects microscopic involuntary motions of the body. Our powerful machine learning engine identifies and analyzes the different contributions made by each of the body’s physiological systems, allowing a one-minute, non-invasive PHYBRATA test to quantify and monitor impairments using the unique biomechanical vibrational signature of each physiological system. The PHYBRATA sensor, mobile app, and cloud-based data services have been integrated into a platform-as-a-service solution licensed to healthcare delivery and research organizations.
Company Overview
PROTXX, Inc. is a very small business founded in 2016, headquartered in Menlo Park, California, with additional locations in Rocklin, California, and Calgary, Alberta. The company operates within the Health, Wellness & Fitness industry, specializing in wearable devices, machine learning, neurology, diagnostics, therapeutics, remote patient management, wellness, athlete performance, and elderly frailty. The team size consists of three members, focusing on innovative solutions for neurophysiological conditions.
Products and Services
The PHYBRATA sensor is a key product of PROTXX, Inc., designed to attach behind the ear using a small disposable adhesive. It detects microscopic involuntary motions of the body and conducts a one-minute, non-invasive test to quantify and monitor impairments across various physiological systems. The PHYBRATA platform integrates the sensor, a mobile app, and cloud-based data services into a platform-as-a-service (PaaS) solution, which is licensed to healthcare delivery and research organizations for both clinical and remote settings.
Technology and Innovation
The machine learning engine developed by PROTXX, Inc. utilizes unique features in PHYBRATA signals to identify, quantify, and monitor neurophysiological impairments. The Clinic mobile app allows users to configure tests and collect data in under a minute, providing instant results. The Clinic platform-as-a-service system enables healthcare providers to monitor patient progress over time and adjust treatments accordingly, enhancing health outcomes.
Collaborations and Partnerships
PROTXX, Inc. engages in various collaborations to advance healthcare solutions. The company partners with Canadian researchers to study peripheral neuropathies and has been involved in remote personalized healthcare initiatives for patients with multiple sclerosis. Additionally, PROTXX collaborates with the Canadian Sport Institute Calgary to improve athlete concussion management. The company also works with Vivo Cura Health to explore minimally invasive pain interventions.
Research and Development
PROTXX, Inc. has a strong focus on research and development, holding 21 patent applications and multiple peer-reviewed publications. The innovations in wearable sensors, machine learning, and remote patient monitoring aim to transform the lives of individuals with neurophysiological conditions, including concussions, stroke, multiple sclerosis, and Parkinson's disease. The PHYBRATA test and sensor technology contribute to advancing diagnostics and therapeutics in the field.